Ovarian Cancer
News and reporting on ovarian cancer.
Carrick Therapeutics Advances Second CDK Inhibitor Into Clinic, Explores Biomarker Approaches
Premium
The Boston-based firm just launched the first trial of a CDK12/13 inhibitor and is anticipating starting Phase III trials for a CDK7 inhibitor in 2026.
Cartherics Raises A$15M, Plans to Evaluate NK-Based Cell Therapy in Ovarian Cancer
With help from the oversubscribed financing round, the Australian firm is eyeing early 2025 for a Phase I clinical trial of its TAG-72-targeting cell therapy.
TORL BioTherapeutics' CLDN6-Targeting Antibody-Drug Conjugate Demonstrates Encouraging Early Results
Premium
Phase I data presented at ESMO suggested that TORL-1-23 may have particularly strong activity in CLDN-positive advanced ovarian cancer.
Population Testing for BRCA1/2 Appears Cost-Effective in Younger Canadian Women
Using simulated data for 1 million women, researchers found that population-based BRCA1/2 testing would be cost-effective, particularly in 30-year-old women.
Epsilogen Raises $16.4M in Series B Expansion to Support Ovarian Cancer Drug Study
The firm will begin a Phase Ib trial exploring its MOv18 immunoglobulin E antibody in folate receptor alpha-positive ovarian cancer.